We work to strengthen the governance and management of Ukraine’s pharmaceutical sector by implementing measures that boost transparency, improve cost efficiency, and promote an effective and sustainable supply chain system. Following Russia’s invasion of Ukraine, we have helped safeguard access to affordable and reliable medicines and health commodities, especially those used to prevent, diagnose, and treat HIV, AIDS, TB, and COVID-19. 

Boxes of health commodities stacked on a trolley at a Ukrainian pharmaceutical warehouse, Ukraine. Photo Credit: Farmasoft

Ensuring uninterrupted access to lifesaving medicines in Ukraine

The chaos and violence of the war has had devastating effects on nearly every aspect of life in Ukraine, including the health care system. The attacks have destroyed hospitals and health clinics, disrupted supply chains, and prevented patients from accessing the care they need. In the immediate aftermath of the invasion and continuing today, we refocused our efforts to combat these wartime challenges and worked with the Government of Ukraine to distribute medical humanitarian aid to those most in need. While many of our project staff have been forced to flee their homes, they remain dedicated to this mission and continue to build on our progress to reform Ukraine’s health care system. In addition to keeping the supply chain intact and establishing public- and private-sector partnerships to maintain an ample supply of medicines, equipment, and medical staff, we will continue to help forge a path forward for Ukraine and provide hope in the midst of uncertainty.


For more than a decade, we have supported efforts in Ukraine to strengthen the country’s health system and improve the availability and use of essential medicines. We work with the Government of Ukraine, civil society, and private-sector partners to bolster pharmaceutical governance and management, contribute to a longer-term plan for pharmaceutical financing, and strengthen the pharmaceutical supply chain system. Our projects have helped ensure that patients in every region of the country can access lifesaving medicines and health commodities for HIV, TB, COVID-19, and more.

Our project staff quickly modified and scaled operations to better support Ukraine in the wake of the war. We continue to distribute medical humanitarian aid to those in need, monitor the supply of medicines and health commodities, and build on our work to promote transparency and sustainability in the overall health system.

  1. Resources
  2. News & Stories

Catalyzing the Growth and Success of the MPU: Lessons From SAFEMed

This technical brief documents the growth and success of the Medical Procurement of Ukraine (MPU) since its inception in 2018.

MSH’s Dr. Rabia Sucu Named President of Health Technology Assessment International, Board of Directors

Dr. Sucu is a technical advisor on pharmaceutical policy and governance for the USAID SAFEMed Activity in Ukraine, where she has led the team’s work to institutionalize Health Technology Assessment (HTA). Her appointment as President of Health Technology Assessment international (HTAi) and its board of directors recognizes Dr. Sucu’s significant contributions to and expertise on HTA—a multidisciplinary process used to determine the value of a drug, diagnostic test, or medical device or procedure at different points in its lifecycle.